Manufacturer Solutions

Cell and Gene Therapy

Your therapy can make all the difference. Together, we’ll unlock its potential.
cell and gene therapy dna strand

Accelerating healthier futures

As healthcare advances, so must the processes that connect patients to the therapies they need. Each patient's path to treatment is unique. And because a rapidly evolving cell and gene therapy industry requires an equally innovative partner, AmerisourceBergen is committed to delivering solutions that enable this connection.

Every innovator needs a connector. We exist to connect you.
Cell and gene therapy commercialization

For therapy developers

Distribution and Commercialization Services

From pre-clinical and commercial logistics to distribution and order to cash solutions, our experts can help you navigate the right options for your therapy. Our extensive reach has served patients for clinical trials and commercial distribution in the US, and in more than 50 countries worldwide.
Cell and gene therapy insights

For providers

Market Access and Reimbursement

We’ve helped commercially support 100% of the cell and gene therapies on the market today. Our experts offer market access, reimbursement and specific therapeutic area insights to help therapy developers understand the unique market landscape.
Cell and gene therapy patient services

For patients

Impacting Patient Support

Hub services provide a holistic and comprehensive approach to ongoing patient support. We have the flexibility to design unique programs incorporating a full array of access, adherence and affordability solutions that meet patient needs. 

Enhancing hub patient services and care team connectivity for cell and gene therapies

With the integration between OCELLOS by Trakcel and Lash Group's Fusion, we are entering a new phase in therapy ecosystem connectivity.
Cell and gene therapy consultants

Working together with therapy developers to identify and overcome barriers

Cell and gene therapy consultants
Our consultative approach and extensive reach across healthcare give us access to the best insights in the industry—insights we leverage to help reduce logistics, order-to-cash, clinical trial, commercialization, and patient support challenges for our partners and the patients they serve.

Cell and gene therapy consultants

Redefining moments that matter

We approach every touchpoint along the cell and gene therapy commercialization and treatment timeline with the patient in mind. When we all collaborate to deliver potentially life-saving solutions, we can start redefining the moments that matter for patients, clinicians and our key stakeholders.
  • Complete data solutions provide visibility to the patient journey

  • Innovative patient access, affordability and adherence solutions unique to cell and gene therapies
  • Expert guidance on market access, reimbursement and policy
  • Complete logistics support, from pre-clinical through clinical trials to commercialization and post-launch solutions to ensure product quality standards are maintained 
  • Established relationships with thousands of healthcare providers optimizes the order to cash process and ease of prodcut access

"AmerisourceBergen has a proven history of bringing complex and transformative therapies to market. But like our cell and gene therapy partners, we're always looking ahead. We want to innovate because there will be new challenges as the field evolves. We are committed to co-creating innovative solutions to meet those challenges."

Lung-I Cheng

Vice President, Cell and Gene Therapy
AmerisourceBergen

Our partnerships

Collaboration is essential to the creation of clinical and commercial scale logistics platforms. In order to support therapy developers, we have integrated systems and technology with a number of key partner organizations.
  • Vineti
  • Cytiva
  • TrakCel
  • BioLife Solutions
  • Advanced Therapies Treatment Centres

biopharma commercialization

Biopharma services

biopharma commercialization

Each investment we make is focused on connecting healthcare stakeholders to accelerate healthier futures. Our unrivaled expertise powers us in our vision to help you fully realize your product’s power—through the patients it reaches and the strategic outcomes it delivers. Learn more about our end to end suite of commercialization solutions for biopharma companies.

Let's work together to envision new paths to healthier futures around the world.

biopharma commercialization

Cell and Gene Therapy Insights

Reimbursement models for CGT

Insight

Evaluating alternative revolutionary reimbursement models to craft a sustainable business model for cell and gene therapies

David Senior
AmerisourceBergen
October 2022

Cell and gene therapy Alternate payer engagement models

Insight

Alternate payer engagement models are changing the landscape


AmerisourceBergen
August 2022

Business meeting

Insight

Navigating reimbursement and access challenges for novel cell and gene therapies

Amanda OHora
AmerisourceBergen
July 2022

lash group consultation

Connect with our cell and gene therapy team

lash group consultation
Schedule some time with our cell and gene therapy experts today. We look forward to hearing from you. 
lash group consultation